Strain-relatedness of methicillin-resistant Staphylococcus aureus isolates recovered from patients with repeated infection

Clinical Infectious Diseases

Volumn 46, Issue 8, 2008, Pages 1241-1247

  Huang, Susan S ^a,b,h   Diekema, Daniel J ^d,e   Warren, David K ^f   Zuccotti, Gianna ^g   Winokur, Patricia L ^d   Tendolkar, Shailesh ^d   Boyken, Linda ^d   Datta, Rupak ^c   Jones, Rebecca M ^f   Ward, Melissa A ^e   Aubrey, Tanya ^g   Onderdonk, Andrew B ^b   Garcia, Christian ^c   Platt, Richard ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; MOXIFLOXACIN; OXACILLIN; PSEUDOMONIC ACID; QUINUPRISTIN; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLINICAL TRIAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR PHYLOGENY; MULTICENTER STUDY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; PHYLOGENY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 42549148582     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/529381     Document Type: Article

References (30)

1. Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis 2007; 13:1840-6.
2. Huang SS, Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 2003; 36:281-5.
3. Huang SS, Hinrichsen VL, Stulgis L, et al. Methicillin-resistant Staphylococcus aureus infection in the year following detection of carriage [abstract 157]. In: Programs and abstracts of the 16th Society of Healthcare Epidemiology of America Annual Meeting (Chicago). Arlington, VA: Society of Healthcare Epidemiology of America, 2006.
4. Loeb M, Main C, Walker-Dilks C, Eady A. Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. Cochrane Database Syst Rev 2003; 4:CD003340.
5. Simor AE, Phillips E, McGeer A, et al. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis 2007; 44:178-85.
6. Parras F, Guerrero C, Bouza E, et al. Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1995; 39:175-9.
7. Kimura A, Mochizuko T, Nishizawa K, Mashiko K, Yamamoto Y, Otsuka T. Trimethoprim-sulfamthoxazole for the prevention of methicillin-resistant Staphylococcus aureus pneumonia in severely burned patients. J Trauma 1998; 45:383-7.
8. Roccaforte JS, Bittner MJ, Stumpf CA, Preheim LC. Attempts to eradicate methicillin-resistant Staphylococcus aureus colonization with the use of trimethoprim-sulfamethoxazole, rifampin, and bacitracin. Am J Infect Control 1988; 16:141-6.
9. Perl TM, Cullen JJ, Wenzel RP, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 2002; 346:1871-7.
10. Kauffman CA, Terpenning MS, He X, et al. Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long-term-care facility with the use of mupirocin ointment. Am J Med 1993; 94:371-8.
11. Harbarth S, Dharan S, Liassine N, Herrault P, Auckenthaler R, Pittet D. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1999; 43:1412-6.
12. Weisman LE, Thackray HM, Gracia-Prats JA, et al. Phase I/II double blind, placebo controlled, dose escalation, safety and pharmacokinetics study in very low birth weight neoneates of BSYX-A110, an anti-staphylococcal monoclonal antibody for the prevention of staphylococcal bloodstream infections [abstract LB14]. In: Programs and abstracts of the Pediatric Academic Societies Annual Meeting (San Francisco). Woodlands, TX: Pediatric Academic Societies, 2004.
13. Shinefield H, Black S, Fattom A, et al. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med 2002; 346:491-6.
14. Fattom A, Fuller S, Propst M, et al. Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX) in hemodialysis patients. Vaccine 2004; 23:656-63.
15. Herwaldt LA, Pottinger JM, Coffman S, Tjaden J. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in a Veterans Administration medical center. Infect Control Hosp Epidemiol 2002; 23:502-5.
16. Maslow JN, Brecher S, Gunn J, Durbin A, Barlow MA, Arbeit RD. Variation and persistence of methicillin-resistant Staphylococcus aureus strains among individual patients over extended periods of time. Eur J Clin Microbiol Infect Dis 1995; 14:282-90.
17. Lim MSC, Marshall CL, Spelman D. Carriage of multiple subtypes of methicillin-resistant Staphylococcus aureus by intensive care unit patients. Infect Control Hosp Epidemiol 2006; 27:1063-7.
18. Von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. New Engl J Med 2001; 344:11-6.
19. Horan TC, Gaynes RP. Surveillance of nosocomial infections. In: Mayhall CG, ed. Hospital epidemiology and infection control. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2004:1659-702.
20. Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002; 46:2155-61.
21. Clinical and Laboratory Standards Institute (formerly National Committee for Clinical Laboratory Standards [NCCLS]). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 5th ed. Approved standard M7-A5. Wayne, PA: NCCLS, 2000.
22. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 16th informational supplement. CLSI document M100-S16. Wayne, PA: CLSI, 2004.
23. Palepou MF, Johnson AP, Cookson BD, et al. Evaluation of disc diffusion and Etest for determining the susceptibility of Staphylococcus aureus to mupirocin. J Antimicrob Chemother 1998; 42:577-83.
24. Diekema DJ, Pfaller MA, Turnidge J, et al. Genetic relatedness of multidrug-resistant, methicillin (oxacillin)-resistant Staphylococcus aureus bloodstream isolates from SENTRY antimicrobial resistance surveillance centers worldwide, 1998. Microb Drug Resist 2000; 6:213-21.
25. Tenover FC, Arbeit RD, Goering RV. How to select and interpret molecular strain typing methods for epidemiological studies of bacterial infections: a review for healthcare epidemiologists: molecular typing working group of the society for healthcare epidemiology of america. Infect Control Hosp Epidemiol 1997; 18:426-39.
26. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 2003; 41:5113-20.
27. Kuehnert MJ, Kruszon-Moran D, Hill HA, et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis 2006; 193:172-9.
28. Boyce JM, Potter-Bynoe G, Chenevert C, King T. Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications. Infect Control Hosp Epidemiol 1997; 18:622-7.
29. Sexton T, Clarke P, O'Neill E, et al. Environmental reservoirs of methicillin-resistant Staphylococcus aureus in isolation rooms: correlation with patient isolates and implications for hospital hygiene. J Hosp Infect 2006; 62:187-94.
30. French GL, Otter JA, Shannon KP, et al. Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): a comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination. J Hosp Infect 2004; 57:31-7.